Greg Schiffman will join StemCells as chief financial officer and executive vice president of finance in January.
Schiffman previously held financial executive posts at Affymetix and Applied Biosystems. He most recently was executive vice president and CFO of Dendreon.
StemCells is Newark, Calif.-based company that specializes in cell-based therapeutics and stem cell-based R&D firm. Schiffman will succeed StemCells' current CFO, Rodney Young, when he assumes his new post next year.
Ingenuity Systems, a Qiagen company that offers web-based genomic data analysis applications, last week announced the formation of a scientific advisory board.
Ingenuity's SAB includes Sherri Bale, managing director and cofounder of GeneDx; Madhuri Hegde, executive director of Emory Genetics Laboratory; and Hákon Hákonarson, director of the Center for Applied Genomics at the Children's Hospital of Philadelphia.
It also includes Doug Basset, Qiagen's chief technology and chief scientific officer; Elaine Mardis, co-director of the Genome Institute at Washington University; Eric Schadt, director of the Icahn Institute for Genomics and Multiscale Biology at Mt. Sinai Hospital; and Jay Shendure, associate professor of genome sciences at the University of Washington.
BioArray News interviewed Emory's Hegde about the use of microarrays and sequencing in molecular diagnostics last month, and spoke with CHOP's Hákonarson about creating a map of human genomic copy number variation in 2009.